Uprosertib

Uprosertib is an orally bioavailable serine/threonine protein kinase Akt (protein kinase B) inhibitor with potential anti-tumor activity. Uprosertib binds to Akt and inhibits Akt activity, thereby possibly inhibiting the PI3K/Akt signaling pathway and tumor cell proliferation and inducing tumor cell apoptosis.
Supplier Alfa Cytology
Product # BC0211
Pricing 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, inquire
Feedback